Ramucirumab is a monoclonal antibody used to treat advanced cancers by inhibiting VEGFR-2, preventing tumor growth. It’s approved for gastric, lung, colorectal, and liver cancers, often combined with chemotherapy for effectiveness.
Get More Insights: https://wemarketresearch.com/r....eports/ramucirumab-m
Like
Comment
Share
